Literature DB >> 17260161

Role of ammonia and inflammation in minimal hepatic encephalopathy.

D L Shawcross1, G Wright, S W M Olde Damink, R Jalan.   

Abstract

BACKGROUND: Minimal hepatic encephalopathy (MHE) is common in cirrhosis but its pathophysiologic basis remains undefined. We evaluated whether the presence of MHE was associated with severity of liver disease, ammonia levels or the presence of inflammation and assessed factors determining neuropsychological deterioration accompanying induction of hyperammonemia.
METHODS: Eighty four cirrhotics were studied. A neuropsychological test battery was performed and blood taken for ammonia, WCC, CRP, nitrate/nitrite, IL-6 and amino acids, before and after, induction of hyperammonemia by administration of a solution mimicking the amino acid composition of haemoglobin (60) or placebo (24).
RESULTS: The presence and severity of MHE were independent of severity of liver disease and ammonia concentration but markers of inflammation were significantly higher in those with MHE compared with those without. Induction of hyperammonemia produced deterioration in one or more neuropsychological tests by > or =1 SD in 73.3%. This was independent of the magnitude of change in plasma ammonia and severity of liver disease but was significantly greater in those with more marked inflammation.
CONCLUSION: Our data show that inflammation is an important determinant of the presence and severity of MHE. The change in neuropsychological function following induced hyperammonemia is greater in those with more severe inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17260161     DOI: 10.1007/s11011-006-9042-1

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  34 in total

Review 1.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 2.  Blood ammonia levels and hepatic encephalopathy.

Authors:  Alan H Lockwood
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

3.  Performance on psychological tests. Demographic and clinical correlates of the results of these tests.

Authors:  C D Frith; J Leary; C Cahill; E C Johnstone
Journal:  Br J Psychiatry Suppl       Date:  1991-10

Review 4.  Pathways and mechanisms for cytokine signaling of the central nervous system.

Authors:  J Licinio; M L Wong
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

Review 5.  Psychomotor function and psychoactive drugs.

Authors:  I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

6.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

7.  Visual attention in cirrhotic patients: a study on covert visual attention orienting.

Authors:  P Amodio; P Marchetti; F Del Piccolo; G Campo; C Rizzo; R M Iemmolo; G Gerunda; L Caregaro; C Merkel; A Gatta
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

8.  Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia.

Authors:  D L Shawcross; S Balata; S W M Olde Damink; P C Hayes; J Wardlaw; I Marshall; N E P Deutz; R Williams; R Jalan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-05-06       Impact factor: 4.052

9.  Subclinical hepatic encephalopathy impairs daily functioning.

Authors:  M Groeneweg; J C Quero; I De Bruijn; I J Hartmann; M L Essink-bot; W C Hop; S W Schalm
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

10.  Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.

Authors:  Qing Liu; Zhong Ping Duan; Da Kang Ha; Stig Bengmark; Jelica Kurtovic; Stephen M Riordan
Journal:  Hepatology       Date:  2004-05       Impact factor: 17.425

View more
  88 in total

Review 1.  Advances in the evaluation and management of minimal hepatic encephalopathy.

Authors:  Jennifer Y Montgomery; Jasmohan S Bajaj
Journal:  Curr Gastroenterol Rep       Date:  2011-02

2.  Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy.

Authors:  Vicente Felipo; Amparo Urios; Encarna Montesinos; Inmaculada Molina; Maria L Garcia-Torres; Miguel Civera; Juan A Del Olmo; Joaquin Ortega; Jose Martinez-Valls; Miguel A Serra; Norberto Cassinello; Abdallah Wassel; Esperanza Jordá; Carmina Montoliu
Journal:  Metab Brain Dis       Date:  2011-11-10       Impact factor: 3.584

Review 3.  Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.

Authors:  Amit S Seyan; Robin D Hughes; Debbie L Shawcross
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

Review 4.  Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.

Authors:  Ming Luo; Jian-Yang Guo; Wu-Kui Cao
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

5.  Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Christine M Schubert; Douglas M Heuman; James B Wade; Douglas P Gibson; Allyne Topaz; Kia Saeian; Muhammad Hafeezullah; Debulon E Bell; Richard K Sterling; R Todd Stravitz; Velimir Luketic; Melanie B White; Arun J Sanyal
Journal:  Gastroenterology       Date:  2010-02-20       Impact factor: 22.682

6.  Factors contributing to the development of overt encephalopathy in liver cirrhosis patients.

Authors:  Motoh Iwasa; Ryosuke Sugimoto; Rumi Mifuji-Moroka; Nagisa Hara; Kyoko Yoshikawa; Hideaki Tanaka; Akiko Eguchi; Norihiko Yamamoto; Kazushi Sugimoto; Yoshinao Kobayashi; Hiroshi Hasegawa; Yoshiyuki Takei
Journal:  Metab Brain Dis       Date:  2016-06-29       Impact factor: 3.584

7.  Surgical attenuation of spontaneous congenital portosystemic shunts in dogs resolves hepatic encephalopathy but not hypermanganesemia.

Authors:  Adam G Gow; Polly E Frowde; Clive M Elwood; Carolyn A Burton; Roger M Powell; Simon W Tappin; Rob D Foale; Andrew Duncan; Richard J Mellanby
Journal:  Metab Brain Dis       Date:  2015-05-05       Impact factor: 3.584

8.  Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis.

Authors:  Yuying Zhang; Yikuan Feng; Bin Cao; Qiang Tian
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 9.  The treatment of hepatic encephalopathy.

Authors:  Marsha Y Morgan; A Blei; K Grüngreiff; R Jalan; G Kircheis; G Marchesini; O Riggio; Karin Weissenborn
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 10.  Systemic inflammation and ammonia in hepatic encephalopathy.

Authors:  Thomas H Tranah; Godhev K Manakkat Vijay; Jennifer M Ryan; Debbie L Shawcross
Journal:  Metab Brain Dis       Date:  2012-12-07       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.